Epigen Biosciences
Biotechnology, Barnes Cyn Rd, San Diego, , 92121, California, 10225, United States, 1-10 Employees
Phone Number: 18*********
Who is EPIGEN BIOSCIENCES
Epigen is an incubator of life science projects focused on developing new product opportunities with strong IP to be advanced into clinical development. We operate through collaboration w...
Read More
-
Headquarters: 10225 Barnes Cyn Rd, San Diego, California, 92121, United States
-
Date Founded: 2010
-
Employees: 1-10
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2834
|
NAICS Code: 561110 |
Show More
Does something look wrong? Fix it. | View contact records from EPIGEN BIOSCIENCES
Epigen Biosciences Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Epigen Biosciences
Answer: Epigen Biosciences's headquarters are located at Barnes Cyn Rd, San Diego, , 92121, California, 10225, United States
Answer: Epigen Biosciences's phone number is 18*********
Answer: Epigen Biosciences's official website is https://epigenbiosciences.com
Answer: Epigen Biosciences's revenue is $1 Million to $5 Million
Answer: Epigen Biosciences's SIC: 2834
Answer: Epigen Biosciences's NAICS: 561110
Answer: Epigen Biosciences has 1-10 employees
Answer: Epigen Biosciences is in Biotechnology
Answer: Epigen Biosciences contact info: Phone number: 18********* Website: https://epigenbiosciences.com
Answer: Epigen is an incubator of life science projects focused on developing new product opportunities with strong IP to be advanced into clinical development. We operate through collaboration with academic groups in their respective areas of expertise. Epigen provides strategic project management and world-class medicinal chemistry support. The company founders have considerable successful experience in drug discovery and development and a track record of advancing compounds to the clinic and commercial registration. Epigens unique operating model provides access to a complete team of experts and resources while keeping low overhead expenses, thus allowing for the efficient development of assets and maximal value creation. The company creates value by bridging the gap between lead identification and clinical proof-of-concept. Ideally, each asset will have a 2-4 years turnaround time from IP to IND enablement and completion of Phase 1 studies. These would then be sold or partnered with Pharma companies.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month